Curation SD5 HOXD13
8.5 + 4 = 12.5 / 18
Genetic evidence
Total: 8.5
Category | Type | Citation | Score | Details |
|---|---|---|---|---|
Singular Evidence | Probands | 6 | Sixteen newly ascertained SPD pedigrees and 4 previously published pedigrees were clinically/genetically reviewed; HOXD13 exon 1 polyalanine expansions of +7, +8, +9, +10, or +14 alanines were identified, with 99 affected individuals examined. | |
Collective Evidence | Allele | 1 | Across 20 SPD pedigrees, larger HOXD13 polyalanine expansions correlated with higher penetrance and greater limb involvement; nonpenetrance was observed only with the smallest (+7 alanine) expansions, and severity increased significantly for hands (P=0.012) and feet (P<0.00005). | |
Collective Evidence | Segregation | 1.5 | In three SPD pedigrees, HOXD13 polyalanine expansion alleles cosegregated with synpolydactyly; affected individuals carried larger PCR products, one homozygous individual had a more severe phenotype, and one clinically unaffected relative was a nonpenetrant heterozygous carrier. |
Experimental evidence
Total: 4
Category | Type | Citation | Score | Details |
|---|---|---|---|---|
Models | Non-human model organism | 4 | Homozygous spdh mouse embryos carrying the Hoxd13 +7A repeat-expansion allele showed synpolydactyly-relevant limb bud defects, altered HOXD13-containing condensates, reduced co-activator overlap, and cell-type-specific transcriptional changes in disease-relevant limb cells. |